Print

Ironwood Pharmaceuticals Chief Executive Breaks Silence on IPO  
3/29/2010 7:12:35 AM

Xconomy.Com -- Peter Hecht is finally able to speak about Ironwood Pharmaceuticals Inc.’s landmark initial public offering, breaking the silence required under quiet-period rules. The Cambridge company’s chief executive gave Xconomy a front-row perspective.
//-->